Benedikt Stegmann

Body mass index (BMI) but not body weight is associated with changes in the metabolism of risperidone; A pharmacokinetics-based hypothesis

Michael Paulzen, Ekkehard Haen, Benedikt Stegmann et al. · Psychoneuroendocrinology · 2016 · 40 citations

Pharmacy, Pharmacokinetics, Pharmacology +11

Effect of smoking on risperidone pharmacokinetics – A multifactorial approach to better predict the influence on drug metabolism

Georgios Schoretsanitis, Ekkehard Haen, Benedikt Stegmann et al. · Schizophrenia Research · 2016 · 31 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Clinical response in a risperidone-medicated naturalistic sample: patients’ characteristics and dose-dependent pharmacokinetic patterns

Michael Paulzen, Ekkehard Haen, Benedikt Stegmann et al. · European Archives of Psychiatry and Clinical Neuroscience · 2016 · 29 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Pharmacokinetic Drug-Drug Interactions of Mood Stabilizers and Risperidone in Patients Under Combined Treatment

Georgios Schoretsanitis, Ekkehard Haen, Gerhard Gründer et al. · Journal of Clinical Psychopharmacology · 2016 · 29 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacokinetic patterns of risperidone-associated adverse drug reactions

Georgios Schoretsanitis, Benedikt Stegmann, Christoph Hiemke et al. · European Journal of Clinical Pharmacology · 2016 · 28 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14